Pushing your Limits with VO2 Max | Dr. Andy Galpin

Galpin frames this as the dominant principle in his coaching practice: 'I can't make an argument for anything else being more important for how long you're going to live of the controllable factors — nothing is going to beat that.' He emphasizes this is not about endurance sport — VO2 max can be improved through HIIT, resistance training (via the peripheral pathway), or steady-state cardio. The key is the outcome metric, not the method.

Galpin notes that people instinctively associate VO2 max with endurance running, but this is not the only path: 'there's multiple ways to increase your VO2 max whether it's high-intensity interval training we know that that's effective.' The peripheral adaptation (muscle quality) means that even resistance training circuits with short rest periods can meaningfully contribute to VO2 max improvement. The best approach combines both: dedicated HIIT sessions for the central stimulus plus resistance training for the peripheral substrate.

Galpin illustrates the mechanism vividly: if walking upstairs takes 70-85% of your leg 1RM, the metabolic demand is enormous — you have to recruit massive amounts of muscle tissue and sustain high energy production, which drives the cardiovascular system to near-maximal output. After serious leg strength training, the same step might require only 10% of 1RM — a trivial demand. The cardiovascular system doesn't need to change at all for you to become dramatically 'fitter' by any functional measure. This insight is particularly powerful for geriatric populations where sarcopenia is the primary cause of perceived cardiovascular limitation.

Galpin explicitly calls out the 'good enough' trap: people hear they have an 'above average' VO2 max and assume no further work is needed. The population data is unambiguous — the 99th percentile individual still has lower all-cause mortality than the 90th percentile individual, and that gap matters. The practical implication: VO2 max should be treated like a bank account you continually try to grow, not a pass/fail test you pass once and move on.

Galpin uses the Olympic weightlifting analogy to illustrate non-linear body-weight scaling: a 70-kg lifter squatting 2x bodyweight is not demonstrating the same physiological achievement as a 100-kg lifter doing the same ratio because the scaling is nonlinear. The same math problem applies to VO2 max. In practice, this means an NFL lineman with a relative VO2 max of 38 mL/kg/min might actually have a larger absolute cardiac output and better metabolic machinery than a recreational runner scored at 48 mL/kg/min. The clinical lesson: always look at functional performance alongside the number.

Lyon and Galpin agree on the bidirectional relationship: healthy muscle is necessary (though not sufficient) for high VO2 max, and high VO2 max demands healthy muscle. Galpin describes the markers of unhealthy muscle: fat infiltration (marbling), disrupted hormone receptor sensitivity (insulin, anabolic hormones, estrogens all dysregulated), poor mitochondrial health, and suboptimal metabolic properties. These are not just cosmetic issues — they are direct physiological caps on oxygen extraction capacity and therefore on VO2 max.

Galpin explains the hazard ratio framing: a HR of 1.4 means a 40% relative increase in risk, not a 40% absolute probability of death. The VO2 max HRs range from 2.6 to 5.2 depending on how far below average — numbers that dwarf the stack of diabetes + smoking + coronary artery disease combined. He emphasizes the quartile logic: the bottom 25% (worse than 75% of peers) compared to the third quartile (25th–50th percentile) still shows ~50% risk reduction. These are not small incremental improvements; they are massive mortality effect sizes. Even moving from the 90th to 99th percentile in VO2 max still confers measurable survival advantage — the curve never flattens.

Galpin walks through the Fick equation in plain language: cardiac output is how much oxygenated blood the heart can pump (HR × stroke volume), and the a-vO2 difference is how much of that oxygen the muscle actually pulls out on each pass. If the muscle has low capillary density, poor mitochondrial function, or is metabolically dysfunctional, oxygen builds up on the arterial side and returns largely unused on the venous side — the peripheral extraction is low. The body then has to kick over to anaerobic metabolism much sooner. This means someone with great lungs and a big heart can still have a capped VO2 max if their muscles are metabolically unhealthy. Conversely, training the muscle — even without any direct cardiovascular training — can dramatically raise VO2 max in deconditioned individuals.

Galpin uses Olympic weightlifting as an analogy: you can't just divide a lifter's total by their body weight linearly — a 70-kg lifter squatting double bodyweight is not equally impressive to a 100-kg lifter doing the same ratio because the scaling is nonlinear. The same distortion applies to VO2 max: a 120-kg athlete with genuinely great cardiorespiratory fitness will score lower in relative terms than a 55-kg athlete with the same absolute capacity. The issue is compounded because smaller people are statistically more likely to have better body composition (lower fat mass relative to total mass), which further inflates their relative VO2 max score. In clinical practice this means relative VO2 max should be interpreted alongside lean body mass data, not as a standalone number.

Galpin explains the stair-climbing analogy: if climbing one flight of stairs demands 70–85% of your leg 1RM, your cardiovascular system has to ramp to match that metabolic demand. But if you double your leg strength, the same staircase now demands only 35–40% of 1RM — a much lower metabolic event — and you barely breathe hard without any change in cardiovascular fitness. The VO2 max improvement is real but it came through the peripheral (muscle) side of the equation. This is particularly relevant in elderly, sarcopenic, or obese populations where poor muscle is the limiting factor rather than cardiac output. In those cases, resistance training first may be the most time-efficient path to improving the longevity metric.

Galpin acknowledges Lyon's expertise as a muscle-focused geriatrician and agrees that healthy muscle is important — but distinguishes quantity from function. He notes that mass beyond the 20–22 threshold is associated with other variables (metabolic health, sleep, mental health) that matter independently, but the pure muscle-mass effect on mortality appears to plateau. By contrast, the dose-response curve for VO2 max and grip/leg strength never plateaus in the population data he's reviewed — including a recent meta-analysis of ~5,000 papers. The implication: if you had to choose one fitness marker to optimize for longevity, it would be VO2 max or strength, not muscle mass.